Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$26,856,439
+$7,310,407 QoQ
Shares Held
22,391
+5.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#761
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GREAT VALLEY ADVISOR GROUP, INC. holds $83,001,641 across 13 Drug Manufacturers - General names. LLY ranks #1 (32.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
22,391 | $26,856,439 | |
| 2 | ABBV |
AbbVie Inc.
|
77,720 | $19,557,460 | |
| 3 | JNJ |
Johnson & Johnson
|
68,669 | $17,439,865 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,166 | $6,060,831 | |
| 5 | AMGN |
Amgen Inc
|
12,332 | $4,465,663 | |
| 6 | NVS |
Novartis AG
|
21,792 | $3,415,242 | |
| 7 | PFE |
Pfizer Inc
|
71,411 | $1,719,576 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
13,687 | $788,644 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,856,439 | 22,391 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $19,546,032 | 21,251 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $20,431,818 | 19,012 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $14,967,771 | 19,617 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,982,429 | 17,937 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,298,212 | 23,366 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $19,111,632 | 24,756 | Shares | Sole | 2025-02-24 | |
| 2024-09-30 | $20,459,898 | 23,094 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $19,354,308 | 21,377 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $15,787,920 | 20,294 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $9,883,991 | 16,956 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $10,005,657 | 18,628 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $8,413,501 | 17,940 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,507,122 | 18,948 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $9,178,925 | 25,090 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $5,552,242 | 17,171 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $7,106,797 | 21,919 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $3,896,350 | 13,606 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $3,655,219 | 13,233 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,026,755 | 13,100 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $2,863,721 | 12,477 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $2,463,595 | 13,187 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $3,136,371 | 18,576 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $2,619,954 | 17,700 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $1,599,113 | 9,740 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||